Markets:

Overview

News

Currencies

International

Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

22.38 +3.59 (+19.11%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates ↗

February 07, 2024

When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.

Via InvestorPlace

2 Beaten-Down Stocks That Are Worth Buying ↗

February 04, 2024

Don't be too quick to ignore these stocks.

Via The Motley Fool

Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand ↗

January 24, 2024

Abbott Laboratories exceeds expectations with Q4 sales of $10.24B, showcasing resilience despite softer demand for COVID-19 testing. CEO anticipates continued growth in 2024.

Via Benzinga

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

January 22, 2024

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

January 08, 2024

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers

December 12, 2023

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.

December 06, 2023

From Tandem Diabetes Care, Inc.

Via Business Wire

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

November 17, 2023

EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END

Via FinancialNewsMedia

NASDAQ:TNDM Investor Notice: Deadline on November 7, 2023 in Lawsuit Against Tandem Diabetes Care, Inc. Coming Up ↗

November 07, 2023

San Diego, CA -- (SBWIRE) -- 11/07/2023 -- The Shareholders Foundation announced that a deadline is coming up on November 7, 2023 in the lawsuit filed for certain investors of Tandem Diabetes Care,...

Via SBWire

Topics Lawsuit

Tandem Diabetes Care Announces Upcoming Conference Presentations

November 06, 2023

From Tandem Diabetes Care, Inc.

Via Business Wire

TNDM DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM

November 06, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

November 06, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

TNDM FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

November 05, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Economy Lawsuit

TNDM IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

November 04, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Economy Lawsuit

TANDEM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm

November 03, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

November 02, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Economy Lawsuit

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 02, 2023

Pre-market stock movers are a hot topic on Thursday and we're checking out all of the biggest ones worth watching this morning!

Via InvestorPlace

US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple ↗

November 02, 2023

After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick.

Via Benzinga

Topics Economy

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 01, 2023

Via Benzinga

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

November 01, 2023

WHY: NEW YORK, NY - (NewMediaWire) - November 01, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August...

Via NewMediaWire

Topics Economy Lawsuit

Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

November 01, 2023

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Announces Third Quarter 2023 Financial Results

November 01, 2023

From Tandem Diabetes Care, Inc.

Via Business Wire

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline

November 01, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM

October 31, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

TNDM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

October 30, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Earnings Scheduled For November 1, 2023 ↗

November 01, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.

Via Benzinga

TANDEM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm

October 29, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

October 28, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Economy Lawsuit

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond ↗

October 26, 2023

The market has punished them, but don't overlook these stocks.

Via The Motley Fool

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.